Showing 1 - 5 results of 5 for search 'Alessandra M. Campos', query time: 0.03s Refine Results
  1. 1
    The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives

    The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives by Joaquim Barreto, Alessandra M. Campos-Staffico, Wilson Nadruz, Thiago Quinaglia, Andrei C. Sposito, Andrei C. Sposito

    Published 2023-09-01
    Get full text
    Article
  2. 2
    278 Eight Pharmacokinetic-related Genetic Variants Were Not Associated with Bleeding from Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients

    278 Eight Pharmacokinetic-related Genetic Variants Were Not Associated with Bleeding from Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients by Alessandra M. Campos-Staffico, Michael P. Dorsch, Geoffrey D. Barnes, Haojie Zhu, Nita A. Limdi, Jasmine A. Luzum

    Published 2023-04-01
    Get full text
    Article
  3. 3
    Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients

    Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients by Alessandra M. Campos-Staffico, Michael P. Dorsch, Geoffrey D. Barnes, Hao-Jie Zhu, Nita A. Limdi, Jasmine A. Luzum

    Published 2022-11-01
    Get full text
    Article
  4. 4
    475 Genetic risk factors for drug-induced long QT syndrome: Findings from a large real-world clinical cohort.

    475 Genetic risk factors for drug-induced long QT syndrome: Findings from a large real-world clinical cohort. by Ana Lopez Medina, Alessandra M. Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P. Jacoby, Mohammed Saeed, Omer Berenfeld, Jasmine A. Luzum

    Published 2024-04-01
    Get full text
    Article
  5. 5
    Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective

    Optimal timing of pharmacoinvasive strategy and its impact on clinical and economic outcomes in patients with ST-elevation myocardial infarction: a real-world perspective by Andrea Dias Stephanus, Alice Pacheco Santos, Ana Carolina Machado Rodrigues da Cunha, Ana Carolina Augusto Rocha, Amanda de Amorim Meireles, Mariana Guimarães Souza de Oliveira, Pietra Arissa Coelho Matsunaga, Alexandre Anderson de Sousa Munhoz Soares, Alexandre Anderson de Sousa Munhoz Soares, Ana Claudia Cavalcante Nogueira, Ana Claudia Cavalcante Nogueira, Ana Claudia Cavalcante Nogueira, Ana Claudia Cavalcante Nogueira, Adriana de J. B. de Almeida Guimarães, Adriana de J. B. de Almeida Guimarães, Gustavo de Almeida Alexim, Alessandra M. Campos-Staffico, Luiz Sergio Fernandes de Carvalho, Luiz Sergio Fernandes de Carvalho, Luiz Sergio Fernandes de Carvalho

    Published 2025-01-01
    Get full text
    Article

Search Tools: